DPP4 inhibitors (gliptins), Tetracyclines and glycylcyclines, Aminoglycosides

0.0(0)
studied byStudied by 0 people
0.0(0)
full-widthCall with Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/68

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai

No study sessions yet.

69 Terms

1
New cards

Sitagliptin, linagliptin and alogliptin are all examples of ...?

Dipeptidylpeptidase-4 inhibitors.

2
New cards

When are DPP-4 inhibitors used in type 2 diabetes?

1) As add-on therapy with metformin (± other agents) if glycaemic control is inadequate,

2) Monotherapy if metformin is contraindicated or not tolerated.

3
New cards

How do DPP-4 inhibitors lower blood glucose?

By inhibiting DPP-4, preventing incretin degradation and increasing active incretin levels.

4
New cards

Why do DPP-4 inhibitors have a low risk of hypoglycaemia?

Incretin effects are glucose-dependent and do not act at normal or low glucose levels.

5
New cards

How do DPP-4 inhibitors differ from sulphonylureas?

They do not stimulate insulin secretion regardless of glucose level.

6
New cards

What are the common side effects of DPP-4 inhibitors?

GI upset, headache, nasopharyngitis and peripheral oedema.

7
New cards

When is hypoglycaemia more likely with DPP-4 inhibitors?

When combined with insulin or sulfonylureas.

8
New cards

What serious but rare adverse effect is associated with DPP-4 inhibitors?

Acute pancreatitis (0.1–1%).

9
New cards

How should suspected pancreatitis be managed in a patient on a DPP-4 inhibitor?

STOP the drug; symptoms should resolve.

10
New cards

In which conditions are DPP-4 inhibitors contraindicated?

Hypersensitivity, type 1 diabetes, ketoacidosis, pregnancy, and breastfeeding.

11
New cards

In which patients should DPP-4 inhibitors be used with caution?

Older adults (>80 years) and those with a history of pancreatitis.

12
New cards

How does renal impairment affect DPP-4 inhibitor use?

Dose reduction may be required in moderate-severe renal impairment.

13
New cards

Which DPP-4 inhibitor should be avoided in hepatic impairment?

Saxagliptin

14
New cards

Which drugs can reduce the effectiveness of DPP-4 inhibitors?

Prednisolone, thiazide and loop diuretics.

15
New cards

Which drugs increase the risk of hypoglycaemia with DPP-4 inhibitors?

Insulin, sulphonylureas, and alcohol.

16
New cards

Why can β-blockers be problematic with DPP-4 inhibitors?

They may mask symptoms of hypoglycaemia.

17
New cards

Can DPP-4 inhibitors be taken with food?

Yes, with or without food.

18
New cards

How is treatment response to DPP-4 inhibitors monitored?

HbA1c measurement.

19
New cards

What HbA1c target is used for DPP-4 inhibitor monotherapy?

<48 mmol/mol.

20
New cards

What HbA1c target is used for DPP-4 inhibitor combination therapy?

<53 mmol/mol.

21
New cards

When should DPP-4 inhibitor therapy usually be intensified (with another agent)?

HbA1c >58 mmol/mol.

22
New cards

What important limitation of DPP-4 inhibitors should be remembered?

No proven reduction in vascular complications and no weight-loss benefit - unlike SGLT-2s and GLP-1s.

23
New cards

Doxycycline and lymecycline are examples of what class antibiotic?

Tetracyclines

24
New cards

What are the common indications for tetracyclines?

1) Acne vulgaris.

2) LRTIs- incl. infective exacerbation of COPD and pneumonia

3) Chlamydial infection- incl. pelvic inflammatory disease.

4) Other- typhoid, malaria and Lyme disease.

25
New cards

When is tigecycline used?

Severe skin, soft-tissue, or abdominal infections where other options are limited.

26
New cards

What is the antimicrobial spectrum of tetracyclines?

Broad spectrum against Gram-positive and Gram-negative organisms.

27
New cards

How does resistance differ between tetracyclines and tigecycline?

Resistance is common with tetracyclines but less problematic with tigecycline.

28
New cards

Are tetracyclines bactericidal or bacteriostatic?

Bacteriostatic.

29
New cards

How do tetracyclines inhibit bacterial growth?

By inhibiting protein synthesis at the 30S ribosomal subunit.

30
New cards

What specific step in protein synthesis is blocked by tetracyclines?

Binding of tRNA to mRNA, preventing amino acid addition.

31
New cards

What is a common mechanism of resistance to tetracyclines?

Efflux pumps that remove the drug from the bacterial cell.

32
New cards

Why is tigecycline less affected by resistance?

It is structurally modified and less susceptible to efflux mechanisms.

33
New cards

Which class of broad-spectrum antibiotic have a lower risk of C. Difficile infection with use?

Tetracyclines.

34
New cards

Is there cross-reactivity between tetracyclines and β-lactam antibiotics?

No.

35
New cards

Name rare but serious adverse effects of tetracyclines.

Hepatotoxicity and intracranial hypertension.

36
New cards

What tetracycline side effects affect the oesophagus and skin?

Oesophageal ulceration/dysphagia and photosensitivity.

37
New cards

What dental effect can tetracyclines cause in children?

Tooth discolouration and enamel hypoplasia.

38
New cards

In which groups are tetracyclines contraindicated?

Pregnancy, breastfeeding, and children ≤12 years.

39
New cards

Why should tetracyclines be used cautiously in renal impairment?

Reduced excretion increases adverse effect risk and anti-anabolic effects raise serum urea.

40
New cards

Which substances reduce tetracycline absorption? What action should be taken when these are co-prescribed?

Calcium, antacids, and iron (divalent cations).

They should therefore not be given within 2 hours of each other.

41
New cards

How do tetracyclines interact with warfarin?

They enhance anticoagulant effect by reducing vitamin K-producing gut bacteria.

42
New cards

How should oral tetracyclines be taken to prevent oesophageal injury?

Swallowed whole with plenty of water while sitting or standing.

43
New cards

What medicines should patients avoid around tetracycline dosing?

Antacids and supplements containing iron or zinc.

44
New cards

What sun-related advice should be given to patients on tetracyclines?

Protect skin from sunlight due to photosensitivity.

45
New cards

How is response to tetracycline therapy monitored?

Resolution of symptoms, signs, and inflammatory markers where appropriate.

46
New cards

What are the main systemic uses of aminoglycosides?

Severe gram -ve infections, incl. sepsis, pyelonephritis/ complicated UTI, intra-abdominal infection, and endocarditis.

47
New cards

Which aminoglycoside is used topically for otitis externa?

Neomycin

48
New cards

Name two commonly used systemic aminoglycosides.

Gentamicin and amikacin.

49
New cards

Against which organisms are aminoglycosides most active?

Gram -ve aerobic bacteria, including Pseudomonas aeruginosa.

50
New cards

Which organisms are aminoglycosides ineffective against?

Streptococci and anaerobes.

51
New cards

Which ribosomal subunit do aminoglycosides bind to?

30S.

52
New cards

Are aminoglycosides bactericidal or bacteriostatic?

Bactericidal.

53
New cards

Why are streptococci and anaerobes intrinsically resistant to aminoglycosides?

They lack the oxygen-dependent transport system needed for drug entry.

54
New cards

How do penicillins enhance aminoglycoside activity?

By weakening the bacterial cell wall and increasing drug penetration.

55
New cards

What are the two most important toxicities of aminoglycosides?

Nephrotoxicity and ototoxicity.

56
New cards

How does aminoglycoside nephrotoxicity present?

Reduced urine output and rising serum creatinine (often reversible).

57
New cards

What symptoms are associated with aminoglycoside ototoxicity?

Hearing loss, tinnitus (cochlear damage), and vertigo (vestibular damage).

58
New cards

Is aminoglycoside-induced ototoxicity reversible?

Often irreversible.

59
New cards

Why must aminoglycoside doses be adjusted carefully?

They are renally excreted and have a narrow therapeutic index.

60
New cards

Which patient groups are at higher risk of aminoglycoside toxicity?

Neonates, older people, and those with renal impairment.

61
New cards

In which neuromuscular condition should aminoglycosides be avoided if possible?

Myasthenia gravis.

62
New cards

Which drugs increase the risk of ototoxicity with aminoglycosides?

Loop diuretics and glycopeptide antibiotics.

63
New cards

Which drugs increase the risk of nephrotoxicity with aminoglycosides?

Cephalosporins, NSAIDs, and other nephrotoxic drugs.

64
New cards

Why must systemic aminoglycosides be given parenterally?

They are NOT absorbed from the GI tract.

65
New cards

What determines aminoglycoside dose and dosing interval?

Body weight, renal function, and plasma drug concentration monitoring.

66
New cards

What trough level is generally considered safe for gentamicin before redosing?

<1 mg/mL.

67
New cards

How long should aminoglycoside treatment usually last?

As short as possible, typically <7 days and often a single dose.

68
New cards

Why is adjusted body weight used for aminoglycoside dosing in obesity?

Aminoglycosides distribute in body water, not fat.

69
New cards

Why should aminoglycosides be infused slowly IV?

To limit high peak concentrations that increase ototoxicity risk.